ENTITY

HJ Science (HJS HK)

5
Analysis
Health Care • Hong Kong

bearish•HJ Science
•15 Jun 2026 08:30

HJ Science IPO: Late Move in Crowded Market Dampens Future Growth Prospect

HJ Science has launched its HK IPO consisting of 14M H shares at HK$81.80 per share to fund ongoing and planned R&D activities for pipeline...

Logo
140 Views
Share
bullish•HJ Science
•12 Jun 2026 17:10

HJ Science (华健未来) IPO: Analysis of Deal Terms

We analyze HJ Science IPO, which targets USD 143m. While valuation is demanding, deal momentum points to likely positive performance.

Logo
171 Views
Share
bearish•HJ Science
•08 Jun 2026 10:00

HJ Science (华健未来) Pre-IPO: Thoughts on Valuation

HJ Science is seeking to raise at least USD100m via a Hong Kong listing. We value the four pipeline assets at USD317m on a China SOTP basis.

Logo
157 Views
Share
bearish•HJ Science
•05 Jun 2026 11:19

HJ Science (华健未来) Pre-IPO: Clinical Evidence Needed for Pipeline Breadth

HJ Science passed the hearing for its HKEX Chapter 18A listing. HJ787 and HJ891 need cleaner pivotal data to justify pipeline breadth.

Logo
137 Views
Share
bullish•Kioxia Holdings
•22 Jun 2026 09:48

Aequitas ECM Weekly (22 June 2026) - SpaceX, GO, Lingyi, SG Micro, Circuit Fab, Merdeka, Kioxia, NSE

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
152 Views
Share
x